Cargando…
Translation of New and Emerging Therapies for Genetic Cardiomyopathies
The primary etiology of a diverse range of cardiomyopathies is now understood to be genetic, creating a new paradigm for targeting treatments on the basis of the underlying molecular cause. This review provides a genetic and etiologic context for the traditional clinical classifications of cardiomyo...
Autores principales: | Helms, Adam S., Thompson, Andrea D., Day, Sharlene M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807730/ https://www.ncbi.nlm.nih.gov/pubmed/35128211 http://dx.doi.org/10.1016/j.jacbts.2021.07.012 |
Ejemplares similares
-
Inherited Thoracic Aortic Disease: New Insights and Translational Targets
por: Fletcher, Alexander J., et al.
Publicado: (2020) -
Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
por: Kim, Kyung-Hee, et al.
Publicado: (2021) -
Transdisciplinary translational science and the case of preterm birth
por: Stevenson, D K, et al.
Publicado: (2013) -
Restrictive cardiomyopathy: definition and diagnosis
por: Rapezzi, Claudio, et al.
Publicado: (2022) -
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)